Breast Cancer Drug Offers New Hope

According to a study conducted by the US National Cancer Institute that included more than 5,000 patients, a new treatment drug for breast cancer has a chance of (along with standard chemotherapy) bettering the chances of recurrence after surgery by more than half.
The drug, called Herceptin, is made by the biotechnology company Genentech Inc., who said they are in process of discussing with federal regulators of prescribing the drug to more patients. Herceptin is considered to be a “targeted therapy”, for it can distinguish and attack diseased cells while leaving the health ones alone.
Just as a reminder, over 40,000 women die of the disease and 211,000 are diagnosed each year. It is the most commonly diagnosed form of cancer in women.